{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:08:43Z","timestamp":1784077723172,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clinthera.2023.09.024","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:32:22Z","timestamp":1699615942000},"page":"1222-1227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Crushing the Contents of Valbenazine Capsules for Potential Addition to Soft Foods or Administration via Gastrostomy Tube"],"prefix":"10.1016","volume":"45","author":[{"given":"Martha","family":"Sajatovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mello","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khody","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.09.024_bib0001","series-title":"Prescribing information","year":"2023"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/jpet.116.239160","article-title":"Pharmacologic characterization of valbenazine (NBI-98854) and its metabolites","volume":"361","author":"Grigoriadis","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0003","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cpdd.1205","article-title":"Pharmacokinetic and pharmacologic characterization of the dihydrotetrabenazine isomers of deutetrabenazine and valbenazine","volume":"12","author":"Brar","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0004","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2017.16091037","article-title":"KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia","volume":"174","author":"Hauser","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(23)00127-8","article-title":"Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"22","author":"Stimming","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00873549","article-title":"Laryngeal tardive dyskinesia","volume":"242","author":"Feve","year":"1995","journal-title":"J Neurol"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0007","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00455-017-9802-6","article-title":"Swallowing disorders in schizophrenia","volume":"32","author":"Kulkarni","year":"2017","journal-title":"Dysphagia"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0008","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12603-022-1743-6","article-title":"Dysphagia, fear of choking and preventive measures in patients with Huntington's disease: the perspectives of patients and caregivers in long-term care","volume":"26","author":"Kalkers","year":"2022","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0009","first-page":"97","article-title":"Dysphagia: evaluation and collaborative management","volume":"103","author":"Wilkinson","year":"2021","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0010","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1111\/bcp.15463","article-title":"Identifying and addressing pill aversion in adults without physiological-related dysphagia: a narrative review","volume":"88","author":"McCloskey","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0011","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0883073811424083","article-title":"A proposed multidisciplinary approach for identifying feeding abnormalities in children with cerebral palsy","volume":"27","author":"Santoro","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0012","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.apmr.2018.05.024","article-title":"Oropharyngeal dysphagia in adults with dyskinetic cerebral palsy and cervical dystonia: a preliminary study","volume":"100","author":"Seo","year":"2019","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0013","first-page":"209","article-title":"Crushing tablets or opening capsules: many uncertainties, some established dangers","volume":"23","year":"2014","journal-title":"Prescrire Int"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0014","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s11096-020-01036-x","article-title":"Appropriateness of oral dosage form modification for aged care residents: a video-recorded observational study","volume":"42","author":"Sefidani Forough","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ejcn.2016.147","article-title":"Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital","volume":"71","author":"Demirkan","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clinthera.2023.09.024_bib0016","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinthera.2023.09.024_sbref0017","series-title":"Use of liquids and\/or soft foods as vehicles for drug administration: general considerations for selection and in vitro methods for product quality assessments. Guidance for Industry","year":"2018"},{"key":"10.1016\/j.clinthera.2023.09.024_sbref0018","series-title":"Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Guidance for Industry","year":"2017"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:00:15Z","timestamp":1758963615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823003909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0149291823003909"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.09.024","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crushing the Contents of Valbenazine Capsules for Potential Addition to Soft Foods or Administration via Gastrostomy Tube","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}